<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04086576</url>
  </required_header>
  <id_info>
    <org_study_id>825273</org_study_id>
    <nct_id>NCT04086576</nct_id>
  </id_info>
  <brief_title>Breathalyzer Validation Study</brief_title>
  <acronym>BVS</acronym>
  <official_title>Reducing Risky Drinking Using Smartphone Paired Breathalyzer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed project will test three commercial cellphone breathalyzers against a police&#xD;
      grade breathalyzer device.The study will test the accuracy of these smartphone breathalyzers&#xD;
      at assessing Breath Alcohol Content (BrAC) against a standard police grade breathalyzer. This&#xD;
      study aims to fill the knowledge gap by determining the validity of smartphone paired&#xD;
      breathalyzer devices to accurately assess BrAC. Data collection includes collection of BrAC&#xD;
      measurements, as well as survey data.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 13, 2016</start_date>
  <completion_date type="Actual">April 17, 2017</completion_date>
  <primary_completion_date type="Actual">April 17, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage Alcohol in Breath Variability</measure>
    <time_frame>8 Hours</time_frame>
    <description>Difference in Breath Alcohol Concentration (BrAC) from police-grade (Intoxilyzer 240) and consumer smartphone-paired breath testing devices relative to Blood Alcohol Concentration (BAC) measured from blood draw after tertiary dose of alcohol.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Differences in Readings on Devices for Percentage of Alcohol in Breath</measure>
    <time_frame>8 Hours</time_frame>
    <description>Mean difference in percent of blood in breath (BrAC) between the police-grade and personal, commercial breath testing devices</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Alcohol Drinking</condition>
  <condition>Alcohol Intoxication</condition>
  <arm_group>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: Drivesafe Evoc, Alcohoot, and BacTrack Pro which will be tested in a randomized order and recorded. Participants blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: BACtrack Vio, Drinkmate, and Floome which will be tested in a randomized order and recorded. Participants blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alcohoot</intervention_name>
    <description>Alcohoot branded smartphone-paired breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BACtrack Mobile Pro</intervention_name>
    <description>BACtrack Mobile Pro branded smartphone-paired breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DRIVESAFE Evoc</intervention_name>
    <description>DRIVESAFE Evoc branded smartphone-paired breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BACtrack Vio</intervention_name>
    <description>BACtrack Vio branded smartphone-paired breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drinkmate</intervention_name>
    <description>Drinkmate branded smartphone-paired breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Floome</intervention_name>
    <description>Floome branded smartphone-paired breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intoxilyzer 240</intervention_name>
    <description>Intoxilyzer 240 police grade breathalyzer</description>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 1</arm_group_label>
    <arm_group_label>Commercial Smartphone-paired breathalyzers-Set 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 21-39 old&#xD;
&#xD;
          -  Less than 4 drinking days and less than 12 drinks per week on average in the past 2&#xD;
             months&#xD;
&#xD;
          -  Have previously consumed four (women) or five (men) or more standard drinks without&#xD;
             problems&#xD;
&#xD;
          -  A valid photo ID&#xD;
&#xD;
          -  Willing to take public transportation home, via septa or an uber rideshare credit.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Desire alcohol treatment now or received it in the past 6 months&#xD;
&#xD;
          -  Alcohol dependence with withdrawal per DSM-V criteria&#xD;
&#xD;
          -  Non-English-speaking&#xD;
&#xD;
          -  Individuals who have a medical condition or who are taking medication which limits or&#xD;
             prevents the consumption of alcohol.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>M. Kit Delgado, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <reference>
    <citation>Alessi SM, Petry NM. A randomized study of cellphone technology to reinforce alcohol abstinence in the natural environment. Addiction. 2013 May;108(5):900-9. doi: 10.1111/add.12093. Epub 2013 Jan 30.</citation>
    <PMID>23279560</PMID>
  </reference>
  <reference>
    <citation>Easton CJ, Swan S, Sinha R. Prevalence of family violence in clients entering substance abuse treatment. J Subst Abuse Treat. 2000 Jan;18(1):23-8.</citation>
    <PMID>10636603</PMID>
  </reference>
  <reference>
    <citation>Harrison EL, Fillmore MT. Are bad drivers more impaired by alcohol? Sober driving precision predicts impairment from alcohol in a simulated driving task. Accid Anal Prev. 2005 Sep;37(5):882-9.</citation>
    <PMID>15907777</PMID>
  </reference>
  <reference>
    <citation>Harrison EL, Marczinski CA, Fillmore MT. Driver training conditions affect sensitivity to the impairing effects of alcohol on a simulated driving test [corrected]. Exp Clin Psychopharmacol. 2007 Dec;15(6):588-98. doi: 10.1037/1064-1297.15.6.588. Erratum in: Exp Clin Psychopharmacol. 2008 Apr;16(2):177.</citation>
    <PMID>18179312</PMID>
  </reference>
  <reference>
    <citation>Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003 May 1;348(18):1786-95. Review.</citation>
    <PMID>12724485</PMID>
  </reference>
  <reference>
    <citation>Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007 Nov 28;298(20):2415-7.</citation>
    <PMID>18042920</PMID>
  </reference>
  <reference>
    <citation>MacKillop J, Amlung MT, Few LR, Ray LA, Sweet LH, Munafò MR. Delayed reward discounting and addictive behavior: a meta-analysis. Psychopharmacology (Berl). 2011 Aug;216(3):305-21. doi: 10.1007/s00213-011-2229-0. Epub 2011 Mar 4.</citation>
    <PMID>21373791</PMID>
  </reference>
  <reference>
    <citation>Marczinski CA, Stamates AL. Artificial sweeteners versus regular mixers increase breath alcohol concentrations in male and female social drinkers. Alcohol Clin Exp Res. 2013 Apr;37(4):696-702. doi: 10.1111/acer.12039. Epub 2012 Dec 6.</citation>
    <PMID>23216417</PMID>
  </reference>
  <reference>
    <citation>McCarthy DM, Niculete ME, Treloar HR, Morris DH, Bartholow BD. Acute alcohol effects on impulsivity: associations with drinking and driving behavior. Addiction. 2012 Dec;107(12):2109-14. doi: 10.1111/j.1360-0443.2012.03974.x. Epub 2012 Aug 10.</citation>
    <PMID>22690907</PMID>
  </reference>
  <reference>
    <citation>McNeill JA, Sherwood GD, Starck PL, Thompson CJ. Assessing clinical outcomes: patient satisfaction with pain management. J Pain Symptom Manage. 1998 Jul;16(1):29-40.</citation>
    <PMID>9707655</PMID>
  </reference>
  <reference>
    <citation>Patel MS, Asch DA, Volpp KG. Wearable devices as facilitators, not drivers, of health behavior change. JAMA. 2015 Feb 3;313(5):459-60. doi: 10.1001/jama.2014.14781.</citation>
    <PMID>25569175</PMID>
  </reference>
  <reference>
    <citation>Naimi TS, Brewer RD, Mokdad A, Denny C, Serdula MK, Marks JS. Binge drinking among US adults. JAMA. 2003 Jan 1;289(1):70-5.</citation>
    <PMID>12503979</PMID>
  </reference>
  <reference>
    <citation>Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 2000 Feb 1;58(1-2):9-25. Review.</citation>
    <PMID>10669051</PMID>
  </reference>
  <reference>
    <citation>Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes, and they will come: contingency management for treatment of alcohol dependence. J Consult Clin Psychol. 2000 Apr;68(2):250-7.</citation>
    <PMID>10780125</PMID>
  </reference>
  <reference>
    <citation>Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 2006 Nov;101(11):1546-60. Review.</citation>
    <PMID>17034434</PMID>
  </reference>
  <reference>
    <citation>Roll JM, Petry NM, Stitzer ML, Brecht ML, Peirce JM, McCann MJ, Blaine J, MacDonald M, DiMaria J, Lucero L, Kellogg S. Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry. 2006 Nov;163(11):1993-9.</citation>
    <PMID>17074952</PMID>
  </reference>
  <reference>
    <citation>Senecal N, Wang T, Thompson E, Kable JW. Normative arguments from experts and peers reduce delay discounting. Judgm Decis Mak. 2012 Sep 1;7(5):568-589.</citation>
    <PMID>23596504</PMID>
  </reference>
  <reference>
    <citation>Sloan FA, Eldred LM, Xu Y. The behavioral economics of drunk driving. J Health Econ. 2014 May;35:64-81. doi: 10.1016/j.jhealeco.2014.01.005. Epub 2014 Feb 11.</citation>
    <PMID>24603444</PMID>
  </reference>
  <reference>
    <citation>Van Dyke N, Fillmore MT. Acute effects of alcohol on inhibitory control and simulated driving in DUI offenders. J Safety Res. 2014 Jun;49:5-11. doi: 10.1016/j.jsr.2014.02.004. Epub 2014 Mar 22.</citation>
    <PMID>24913486</PMID>
  </reference>
  <reference>
    <citation>Watson PE, Watson ID, Batt RD. Prediction of blood alcohol concentrations in human subjects. Updating the Widmark Equation. J Stud Alcohol. 1981 Jul;42(7):547-56.</citation>
    <PMID>7289599</PMID>
  </reference>
  <reference>
    <citation>White A, Hingson R. The burden of alcohol use: excessive alcohol consumption and related consequences among college students. Alcohol Res. 2013;35(2):201-18. Review.</citation>
    <PMID>24881329</PMID>
  </reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 3, 2019</study_first_submitted>
  <study_first_submitted_qc>September 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 11, 2019</study_first_posted>
  <results_first_submitted>February 20, 2020</results_first_submitted>
  <results_first_submitted_qc>September 25, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 20, 2020</results_first_posted>
  <last_update_submitted>September 25, 2020</last_update_submitted>
  <last_update_submitted_qc>September 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholic Intoxication</mesh_term>
    <mesh_term>Alcohol Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 21, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/76/NCT04086576/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Commercial Smartphone-paired Breathalyzers-Set 1</title>
          <description>Smartphone-paired mobile breathalyzer-Set 1: All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: Drivesafe Evoc, Alcohoot, and BacTrack Pro which will be tested in a randomized order and recorded. Participants' blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device. After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.</description>
        </group>
        <group group_id="P2">
          <title>Commercial Smartphone-paired Breathalyzers-Set 2</title>
          <description>Smartphone-paired mobile breathalyzer-Set 2: All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: BACtrack Vio, Drinkmate, and Floome which will be tested in a randomized order and recorded. Participants' blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device. After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Commercial Smartphone-paired Breathalyzers-Set 1</title>
          <description>Smartphone-paired mobile breathalyzer-Set 1: All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: Drivesafe Evoc, Alcohoot, and BacTrack Pro which will be tested in a randomized order and recorded. Participants' blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device. After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.</description>
        </group>
        <group group_id="B2">
          <title>Commercial Smartphone-paired Breathalyzers-Set 2</title>
          <description>Smartphone-paired mobile breathalyzer-Set 2: All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: BACtrack Vio, Drinkmate, and Floome which will be tested in a randomized order and recorded. Participants' blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device. After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.2" spread="3.9"/>
                    <measurement group_id="B2" value="26.3" spread="2.5"/>
                    <measurement group_id="B3" value="26.8" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI (mean ± SD)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.4" spread="4.6"/>
                    <measurement group_id="B2" value="24.7" spread="4.3"/>
                    <measurement group_id="B3" value="24.6" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage Alcohol in Breath Variability</title>
        <description>Difference in Breath Alcohol Concentration (BrAC) from police-grade (Intoxilyzer 240) and consumer smartphone-paired breath testing devices relative to Blood Alcohol Concentration (BAC) measured from blood draw after tertiary dose of alcohol.</description>
        <time_frame>8 Hours</time_frame>
        <population>Group 1: Alcohoot, Evoc, BACtrack Mobile Pro, Intoxilyzer 240 (A). Group 2: BACtrack Vio, Drinkmate, Floome, Intoxilyzer 240 (B). Percent of Alcohol in Blood - grouped.</population>
        <group_list>
          <group group_id="O1">
            <title>Alcohoot</title>
            <description>Alcohoot branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O2">
            <title>BACtrack Mobile Pro</title>
            <description>BACtrack Mobile Pro branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O3">
            <title>DRIVESAFE Evoc</title>
            <description>DRIVESAFE Evoc branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O4">
            <title>Intoxilyzer 240 (A)</title>
            <description>Intoxilyzer 240 police grade breathalyzer</description>
          </group>
          <group group_id="O5">
            <title>BACtrack Vio</title>
            <description>BACtrack Vio branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O6">
            <title>Drinkmate</title>
            <description>Drinkmate branded smartphone-paired breathlyzer</description>
          </group>
          <group group_id="O7">
            <title>Floome</title>
            <description>Floome branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O8">
            <title>Intoxilyzer 240 (B)</title>
            <description>Intoxilyzer 240 police grade breathalyzer</description>
          </group>
          <group group_id="O9">
            <title>Percent of Alcohol in Blood</title>
            <description>Percentage of Alcohol in Blood measured from blood draw</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Alcohol in Breath Variability</title>
          <description>Difference in Breath Alcohol Concentration (BrAC) from police-grade (Intoxilyzer 240) and consumer smartphone-paired breath testing devices relative to Blood Alcohol Concentration (BAC) measured from blood draw after tertiary dose of alcohol.</description>
          <population>Group 1: Alcohoot, Evoc, BACtrack Mobile Pro, Intoxilyzer 240 (A). Group 2: BACtrack Vio, Drinkmate, Floome, Intoxilyzer 240 (B). Percent of Alcohol in Blood - grouped.</population>
          <units>percentage of alcohol</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
                <count group_id="O7" value="10"/>
                <count group_id="O8" value="10"/>
                <count group_id="O9" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0912" spread="0.0164"/>
                    <measurement group_id="O2" value="0.0968" spread="0.0147"/>
                    <measurement group_id="O3" value="0.0694" spread="0.0074"/>
                    <measurement group_id="O4" value="0.0912" spread="0.0099"/>
                    <measurement group_id="O5" value="0.0746" spread="0.0312"/>
                    <measurement group_id="O6" value="0.0495" spread="0.0181"/>
                    <measurement group_id="O7" value="0.0770" spread="0.0194"/>
                    <measurement group_id="O8" value="0.0860" spread="0.0160"/>
                    <measurement group_id="O9" value="0.0996" spread="0.0165"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O4</group_id>
              <group_id>O8</group_id>
            </group_id_list>
            <groups_desc>Each breathalyzer is compared to the percentage of alcohol in the blood during the time of blood draw (90 minutes).</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;.0001</p_value>
            <p_value_desc>Yes, used Tukey Kramer pairwise comparisons to adjust for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
            <method_desc>ANOVA in repeated measures</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Differences in Readings on Devices for Percentage of Alcohol in Breath</title>
        <description>Mean difference in percent of blood in breath (BrAC) between the police-grade and personal, commercial breath testing devices</description>
        <time_frame>8 Hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alcohoot</title>
            <description>Alcohoot branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O2">
            <title>BACtrack Mobile Pro</title>
            <description>BACtrack Mobile Pro branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O3">
            <title>DRIVESAFE Evoc</title>
            <description>DRIVESAFE Evoc branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O4">
            <title>BACtrack Vio</title>
            <description>BACtrack Vio branded smartphone-paired breathalyzer</description>
          </group>
          <group group_id="O5">
            <title>Drinkmate</title>
            <description>Drinkmate branded smartphone-paired breathlyzer</description>
          </group>
          <group group_id="O6">
            <title>Floome</title>
            <description>Floome branded smartphone-paired breathalyzer</description>
          </group>
        </group_list>
        <measure>
          <title>Differences in Readings on Devices for Percentage of Alcohol in Breath</title>
          <description>Mean difference in percent of blood in breath (BrAC) between the police-grade and personal, commercial breath testing devices</description>
          <units>percentage of alcohol in breath</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
                <count group_id="O3" value="10"/>
                <count group_id="O4" value="10"/>
                <count group_id="O5" value="10"/>
                <count group_id="O6" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.000836" lower_limit="-0.003066" upper_limit="0.001394"/>
                    <measurement group_id="O2" value="0.005853" lower_limit="0.003643" upper_limit="0.008064"/>
                    <measurement group_id="O3" value="-0.015698" lower_limit="-0.017905" upper_limit="-0.013491"/>
                    <measurement group_id="O4" value="-0.000405" lower_limit="-0.00345" upper_limit="0.002639"/>
                    <measurement group_id="O5" value="-0.014616" lower_limit="-0.017642" upper_limit="-0.01159"/>
                    <measurement group_id="O6" value="-0.006004" lower_limit="-0.009094" upper_limit="-0.002915"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>8 hours</time_frame>
      <desc>Screening for eligibility reduced risk of all risk mortality</desc>
      <group_list>
        <group group_id="E1">
          <title>Commercial Smartphone-paired Breathalyzers-Set 1</title>
          <description>All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: Drivesafe Evoc, Alcohoot, and BacTrack Pro which will be tested in a randomized order and recorded. Participants blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.&#xD;
Alcohoot: Alcohoot branded smartphone-paired breathalyzer&#xD;
BACtrack Mobile Pro: BACtrack Mobile Pro branded smartphone-paired breathalyzer&#xD;
DRIVESAFE Evoc: DRIVESAFE Evoc branded smartphone-paired breathalyzer&#xD;
Intoxilyzer 240: Intoxilyzer 240 police grade breathalyzer</description>
        </group>
        <group group_id="E2">
          <title>Commercial Smartphone-paired Breathalyzers-Set 2</title>
          <description>All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: BACtrack Vio, Drinkmate, and Floome which will be tested in a randomized order and recorded. Participants blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.&#xD;
BACtrack Vio: BACtrack Vio branded smartphone-paired breathalyzer&#xD;
Drinkmate: Drinkmate branded smartphone-paired breathalyzer&#xD;
Floome: Floome branded smartphone-paired breathalyzer&#xD;
Intoxilyzer 240: Intoxilyzer 240 police grade breathalyzer</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jessie Hemmons</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>215-746-8255</phone>
      <email>jhemmons@pennmedicine.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

